<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="nl">
	<id>https://informatiestandaarden.test-nictiz.nl/index.php?action=history&amp;feed=atom&amp;title=mp%3AV2.0.0_testgegevens_medicatiegegevens_MA_addendum</id>
	<title>mp:V2.0.0 testgegevens medicatiegegevens MA addendum - Bewerkingsoverzicht</title>
	<link rel="self" type="application/atom+xml" href="https://informatiestandaarden.test-nictiz.nl/index.php?action=history&amp;feed=atom&amp;title=mp%3AV2.0.0_testgegevens_medicatiegegevens_MA_addendum"/>
	<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;action=history"/>
	<updated>2026-05-17T13:37:18Z</updated>
	<subtitle>Bewerkingsoverzicht voor deze pagina op de wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;diff=142773&amp;oldid=prev</id>
		<title>Tim Schuller op 17 nov 2022 om 09:52</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;diff=142773&amp;oldid=prev"/>
		<updated>2022-11-17T09:52:00Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;a href=&quot;https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;amp;diff=142773&amp;amp;oldid=130964&quot;&gt;Wijzigingen bekijken&lt;/a&gt;</summary>
		<author><name>Tim Schuller</name></author>
	</entry>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;diff=130964&amp;oldid=prev</id>
		<title>Marijke van Geijn op 2 sep 2022 om 12:22</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;diff=130964&amp;oldid=prev"/>
		<updated>2022-09-02T12:22:11Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;a href=&quot;https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;amp;diff=130964&amp;amp;oldid=112614&quot;&gt;Wijzigingen bekijken&lt;/a&gt;</summary>
		<author><name>Marijke van Geijn</name></author>
	</entry>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;diff=112614&amp;oldid=prev</id>
		<title>Marijke van Geijn op 23 mei 2022 om 11:59</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;diff=112614&amp;oldid=prev"/>
		<updated>2022-05-23T11:59:58Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;nl&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Oudere versie&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Versie van 23 mei 2022 11:59&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l3024&quot;&gt;Regel 3.024:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 3.024:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-style=&amp;quot;vertical-align:top; background-color: #E3E3E3;;&amp;quot;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-style=&amp;quot;vertical-align:top; background-color: #E3E3E3;;&amp;quot;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|colspan=&amp;quot;3&amp;quot;|Reden van voorschrijven&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|colspan=&amp;quot;3&amp;quot;|Reden van voorschrijven&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|style=&quot;background-color: white;&quot;|&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;overig &lt;/del&gt;(code = &#039;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;OTH&lt;/del&gt;&#039; in codeSystem &#039;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;HL7 NullFlavor&lt;/del&gt;&#039;): Reumatoide artritis&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|style=&quot;background-color: white;&quot;|&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Reumatoide artritis &lt;/ins&gt;(code = &#039;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;L88.01&lt;/ins&gt;&#039; in codeSystem &#039;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;ICPC-1&lt;/ins&gt;&#039;): Reumatoide artritis&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-style=&amp;quot;vertical-align:top; background-color: #E3E3E3;;&amp;quot;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|-style=&amp;quot;vertical-align:top; background-color: #E3E3E3;;&amp;quot;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|colspan=&amp;quot;3&amp;quot;|Geneesmiddel - primaire code&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|colspan=&amp;quot;3&amp;quot;|Geneesmiddel - primaire code&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Marijke van Geijn</name></author>
	</entry>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;diff=103307&amp;oldid=prev</id>
		<title>Marijke van Geijn op 22 mrt 2022 om 10:26</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;diff=103307&amp;oldid=prev"/>
		<updated>2022-03-22T10:26:27Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;a href=&quot;https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;amp;diff=103307&amp;amp;oldid=103038&quot;&gt;Wijzigingen bekijken&lt;/a&gt;</summary>
		<author><name>Marijke van Geijn</name></author>
	</entry>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;diff=103038&amp;oldid=prev</id>
		<title>Marijke van Geijn op 15 mrt 2022 om 15:20</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;diff=103038&amp;oldid=prev"/>
		<updated>2022-03-15T15:20:22Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;a href=&quot;https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;amp;diff=103038&amp;amp;oldid=102908&quot;&gt;Wijzigingen bekijken&lt;/a&gt;</summary>
		<author><name>Marijke van Geijn</name></author>
	</entry>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;diff=102908&amp;oldid=prev</id>
		<title>Marijke van Geijn op 10 mrt 2022 om 13:04</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;diff=102908&amp;oldid=prev"/>
		<updated>2022-03-10T13:04:24Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;a href=&quot;https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;amp;diff=102908&amp;amp;oldid=96230&quot;&gt;Wijzigingen bekijken&lt;/a&gt;</summary>
		<author><name>Marijke van Geijn</name></author>
	</entry>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;diff=96230&amp;oldid=prev</id>
		<title>Marijke van Geijn op 28 feb 2022 om 07:46</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;diff=96230&amp;oldid=prev"/>
		<updated>2022-02-28T07:46:16Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;a href=&quot;https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;amp;diff=96230&amp;amp;oldid=92283&quot;&gt;Wijzigingen bekijken&lt;/a&gt;</summary>
		<author><name>Marijke van Geijn</name></author>
	</entry>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;diff=92283&amp;oldid=prev</id>
		<title>Marijke van Geijn op 25 jan 2022 om 13:41</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;diff=92283&amp;oldid=prev"/>
		<updated>2022-01-25T13:41:43Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;a href=&quot;https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;amp;diff=92283&amp;amp;oldid=90970&quot;&gt;Wijzigingen bekijken&lt;/a&gt;</summary>
		<author><name>Marijke van Geijn</name></author>
	</entry>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;diff=90970&amp;oldid=prev</id>
		<title>Marijke van Geijn: Nieuwe pagina aangemaakt met &#039; __NUMBEREDHEADINGS__ {{DISPLAYTITLE:Beschikbaarstellen medicatiegegevens 9 2.0 - MA: addendum inhoudelijke gegevens kwalificatie}}  =Addenda voor inhoudelijke gege...&#039;</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;diff=90970&amp;oldid=prev"/>
		<updated>2022-01-06T09:24:16Z</updated>

		<summary type="html">&lt;p&gt;Nieuwe pagina aangemaakt met &amp;#039; __NUMBEREDHEADINGS__ {{DISPLAYTITLE:Beschikbaarstellen medicatiegegevens 9 2.0 - MA: addendum inhoudelijke gegevens kwalificatie}}  =Addenda voor inhoudelijke gege...&amp;#039;&lt;/p&gt;
&lt;a href=&quot;https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum&amp;amp;diff=90970&quot;&gt;Wijzigingen bekijken&lt;/a&gt;</summary>
		<author><name>Marijke van Geijn</name></author>
	</entry>
</feed>